The Take 5 Campaign: Effects of an Intervention to Promote Five-Day Durations of Antibiotic Therapy for Common Infections in Urgent Care 

  09 September 2025

This quasi-experimental study evaluated the Take 5 campaign, an intervention promoting five-day antibiotic courses for common infections in urgent care. Conducted at two centers (2017–2023), it targeted skin infections, UTIs, sinusitis, otitis media, pneumonia, and COPD exacerbations. The campaign led to an immediate 10.7% rise in ≤5-day prescriptions and a continued monthly increase, raising adherence from 57.5% to 82.9%. Importantly, shorter durations did not increase subsequent antibiotic use or hospitalizations. Overall, the Take 5 intervention effectively reduced unnecessary antibiotic exposure without compromising patient outcomes.

Author(s): Timothy C Jenkins et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!